Literature DB >> 23364598

Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.

Meiting Cai1, Qixing Chen, Chi Chen, Xiwang Liu, Jinchao Hou, Congli Zeng, Qiang Shu, Xiangming Fang.   

Abstract

BACKGROUND: Triggering receptor expressed on myeloid cells-1 (TREM-1) can amplify the proinflammatory response and may contribute to the pathogenesis of inflammatory disease such as sepsis. However, the role of TREM-1 in monocyte fate and the detailed molecular mechanisms evoked by TREM-1 are unknown.
METHODS: Adenoviruses overexpressing TREM-1 were constructed and transfected into a monocytic cell line. After activation of TREM-1 by agonist antibody with or without lipopolysaccharide, apoptosis was induced and assayed using flow cytometry. The signaling pathways downstream of TREM-1 were illustrated by inhibitory experiments. Proapoptotic/antiapoptotic protein levels were measured using immunoblot. In addition, the relationship between the expression levels of TREM-1 in monocytes and the magnitude of monocyte apoptosis were analyzed in septic patients.
RESULTS: Activation of TREM-1 protected monocytes from staurosporine-induced apoptosis. This characteristic was also obtained under lipopolysaccharide stimulation. The protection of TREM-1 against monocyte apoptosis was abrogated after inhibition of extracellular signal-regulated kinase or v-akt murine thymoma viral oncogene homologue signaling. Cross-linking of TREM-1 remarkably up-regulated myeloid cell leukemia-1 protein level, and inhibition of extracellular signal-regulated kinase or v-akt murine thymoma viral oncogene homologue resulted in the reduction of myeloid cell leukemia-1 expression. Inhibition of myeloid cell leukemia-1 abolished the antiapoptotic effect of TREM-1. Furthermore, in septic patients, TREM-1 levels were inversely correlated to the magnitude of apoptosis in monocyte.
CONCLUSIONS: TREM-1 played an important role in apoptosis in monocytes. Activation of TREM-1 protected monocytic cells from apoptosis through activation of both extracellular signal-regulated kinase and v-akt murine thymoma viral oncogene homologue pathways and increased expression of myeloid cell leukemia-1 protein. These findings provide a novel additional mechanism for TREM-1-mediated hyperinflammatory response in monocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23364598     DOI: 10.1097/ALN.0b013e31828744a5

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  4 in total

1.  Porphyromonas gingivalis regulates TREM-1 in human polymorphonuclear neutrophils via its gingipains.

Authors:  Nagihan Bostanci; Thomas Thurnheer; Joseph Aduse-Opoku; Michael A Curtis; Annelies S Zinkernagel; Georgios N Belibasakis
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

2.  TREM-1 deficiency can attenuate disease severity without affecting pathogen clearance.

Authors:  Benjamin Weber; Steffen Schuster; Daniel Zysset; Silvia Rihs; Nina Dickgreber; Christian Schürch; Carsten Riether; Mark Siegrist; Christoph Schneider; Helga Pawelski; Ursina Gurzeler; Pascal Ziltener; Vera Genitsch; Fabienne Tacchini-Cottier; Adrian Ochsenbein; Willy Hofstetter; Manfred Kopf; Thomas Kaufmann; Annette Oxenius; Walter Reith; Leslie Saurer; Christoph Mueller
Journal:  PLoS Pathog       Date:  2014-01-16       Impact factor: 6.823

3.  TRIM22-Mediated Apoptosis is Associated with Bak Oligomerization in Monocytes.

Authors:  Chi Chen; DongYan Zhao; Shu Fang; QiXing Chen; BaoLi Cheng; XiangMing Fang; Qiang Shu
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

4.  Immune and endothelial activation markers and risk stratification of childhood pneumonia in Uganda: A secondary analysis of a prospective cohort study.

Authors:  Chloe R McDonald; Aleksandra Leligdowicz; Andrea L Conroy; Andrea M Weckman; Melissa Richard-Greenblatt; Michelle Ngai; Clara Erice; Kathleen Zhong; Sophie Namasopo; Robert O Opoka; Michael T Hawkes; Kevin C Kain
Journal:  PLoS Med       Date:  2022-07-13       Impact factor: 11.613

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.